Sept. 17, 2025
| Today’s news and insights for medtech leaders
The companies will develop a robotic system to improve patient outcomes in complex hemorrhagic cases and time-sensitive ischemic strokes.
|
BD, which has not received any complaints related to the issue, previously discontinued the devices affected by the expanded recall.
|
The continuing resolution would fund the government, and preserve the flexibilities, through Nov. 21. But the bill makes no mention of extending more generous financial assistance for people who buy plans on the exchanges.
|
Breakthrough medical technologies—from cardiac ablation devices to OTC glucose sensors—are disrupting established markets and creating new revenue streams across the industry. Read the latest on new devices in
|
Deep Dive
Some firms, such as Aidoc, are working directly with the FDA. Others, such as HOPPR, are offering their foundation models for medtech companies to build their own AI tools.
|
News Roundup
Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.
|
From Our Library
Playbook
Custom content for Werner
|
Trendline
Supported by UFP Technologies Inc.
|
View all resources
What We're Reading
Stat
|
The Wall Street Journal
|
KFF Health News
|
| 
